UnknownMar 17, 2021|2 min readBy DDNews StaffRoche gains GenMarkRoche will acquire the California-based diagnostics company for $1.8 billion
UnknownMar 10, 2021|2 min readBy DDNews StaffIn-vitro investmentCELLINK to expand testing offerings with acquisition of MatTek
UnknownFeb 26, 2021|2 min readBy Mel J. YeatesThermo Fisher acquires Mesa BiotechThermo Fisher has completed the acquisition of Mesa Biotech and its Accula System PCR testing platform
UnknownFeb 04, 2021|3 min readBy DDNews StaffNew growth is on the HorizonHorizon to acquire Viela Bio for $3.05B
Tools & Techniques NewsJan 26, 2021|3 min readBy Mel J. YeatesJameel Clinic teams up with Sanofi on AI and machine learningThe collaboration will develop and apply deep learning and machine learning for drug discovery
Cancer ResearchJan 26, 2021|2 min readBy DDNews StaffChimerix acquires OncoceuticsMove will expand Chimerix pipeline with late-stage oncology program
UnknownJan 16, 2021|2 min readBy Mel J. YeatesThermo Fisher Scientific buys Henogen from NovasepAcquisition will expand Thermo Fisher’s global capacity for cell and gene therapies
UnknownJan 07, 2021|2 min readBy DDNews StaffCharles River snags partner Distributed Bio for $83MDistributed Bio adds large-molecule discovery platform to Charles River's repertoire
UnknownDec 23, 2020|2 min readBy DDNews StaffServier pays $2 billion for Agios' oncology businessThe deal nets Servier a clinical oncology portfolio and will expand its U.S. footprint
Infectious Disease & VaccinesNov 25, 2020|2 min readBy DDNews StaffMerck snaps up OncoImmune for $425MThe acquisition nets Merck a pipeline of oncology programs as well as CD24Fc, OncoImmune's lead candidate for the treatment of COVID-19